Skip to main content

Life Sciences

By Anthony Vecchione | 12:24 pm | September 05, 2025
The alliance will center on the discovery, development and commercialization of radioligand therapies for imaging and treatment of solid tumors.
By Anthony Vecchione | 02:01 pm | September 04, 2025
The aim of Agent Studio is to free up teams, accelerate trials, reduce costs and bring medicines to patients faster.
By Anthony Vecchione | 12:47 pm | September 02, 2025
The acquisition joins SeqOne's platform for sequencing analysis with Congenica's clinical decision support technology.
By Anthony Vecchione | 01:32 pm | August 29, 2025
The alliance aims to accelerate clinical trial recruitment by using large language models to hasten and scale patient identification.
By Anthony Vecchione | 02:44 pm | August 25, 2025
The acquisition will allow Tempus to expand its technical team and create a stronger presence in digital pathology.
By Anthony Vecchione | 02:35 pm | August 25, 2025
Ozempic and Wegovy pens will be available via GoodRx for $499 per month.
By Anthony Vecchione | 02:02 pm | August 22, 2025
International Space Station-sponsored investigations target stem cells and microbial infections in space.
By Anthony Vecchione | 12:10 pm | August 22, 2025
Inbox Health's patient billing team will be responsible for overseeing inbound calls, chat and email for CHE Behavioral Health Services' patient queries.
By Anthony Vecchione | 04:34 pm | August 20, 2025
The Alzheimer's Disease Data Initiative is accepting applications for a $1 million first prize for agentic AI Alzheimer's research.
By Anthony Vecchione | 02:10 pm | August 19, 2025
The partnerships come in the wake of an eight-year legal battle in which IQVIA accused Veeva of stealing trade secrets.